Menald Pharmaceuticals Private Limited

Produces and sells pharmaceutical, medicinal, chemical, and botanical products.

2017 | Delhi (India) | Active
Last Updated:

Menald Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 5 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 0.70 M
  • Revenue Growth 0.50%
  • Profit Growth -6.68%
  • Ebitda 9.31%
  • Net Worth 73.17%
  • Total Assets -27.10%

About Menald Pharmaceuticals

Menald Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 2017 (Eight years and five months 2 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹0.70 M.

Mohammad Akhtar, Asma Rais, and Aparajita Panda serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999DL2017PTC310431

  • Company No.

    310431

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    11 Jan 2017

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Menald Pharmaceuticals Private Limited

Explore comprehensive data for Menald Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Menald Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Mohammad Akhtar Country flag representing In Director 11-Jan-2017Current
Asma Rais Country flag representing In Director 14-May-2019Current
Aparajita Panda Country flag representing In Director 14-May-2019Current

Financial Performance of Menald Pharmaceuticals.

Menald Pharmaceuticals Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 0.5% increase. The company also saw a slight decrease in profitability, with a 6.68% decrease in profit. The company's net worth Soared by an impressive increase of 73.17%.

Menald Pharmaceuticals revenue growth over time
Menald Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
0.50%
Revenue from Operations
0.42%
Total Assets
-27.10%
Profit or Loss
-6.68%
Net Worth
73.17%
EBITDA
9.31%

What is the Ownership and Shareholding Structure of Menald Pharmaceuticals?

In 2019, Menald Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.70 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 0.07 Cr

Latest Charge Details

DateLenderAmountStatus
03 Sep 2018Others₹0.70 MOpen

How Many Employees Work at Menald Pharmaceuticals?

Unlock and access historical data on people associated with Menald Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Menald Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Menald Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Menald Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Menald Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Menald Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

  • Balance Sheet

    Menald Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.

  • Director Appointment

    Asma Rais was appointed as a Director was appointed as a Director on 14 May 2019 & has been associated with this company since 6 years 1 month .

  • Director Appointment

    Aparajita Panda was appointed as a Director was appointed as a Director on 14 May 2019 & has been associated with this company since 6 years 1 month .

  • Charges

    A charge with Others of Rs. 0.70 M registered on 03 Sep 2018 with Charge ID 100217104 was modified on 08 May 2019.

  • Charges

    A charge with Others amounted to Rs. 0.70 M with Charge ID 100217104 was registered on 03 Sep 2018.

Frequently asked questions

  • What is the Incorporation or founding date of Menald Pharmaceuticals Private Limited?

    Menald Pharmaceuticals Private Limited was incorporated on 11 Jan 2017.

  • What is authorized share capital and paid-up capital of Menald Pharmaceuticals Private Limited?

    The authorized share capital of Menald Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Menald Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Menald Pharmaceuticals Private Limited.

    • Mohammad Noman Akhtar
    • Asma Rais
    • Aparajita Panda

  • What is the registered address of Menald Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Menald Pharmaceuticals Private Limited is House No. N-84 Second Floor Thokar 05 Abul Fazal Enclave Part-I Jamia Nagar Okhla, India, New Delhi, 110025.

  • What is the corporate identification number (CIN) and company number of Menald Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Menald Pharmaceuticals Private Limited is U74999DL2017PTC310431 and the company number is 310431 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Menald Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2019, the revenue trend for Menald Pharmaceuticals Private Limited has risen by 0.50%.

  • What change has been observed in the net worth of Menald Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2019 indicates that The net worth of Menald Pharmaceuticals Private Limited has experienced an upsurge of 73.17%.

  • What are the total open charges for Menald Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2019, The total open charges for Menald Pharmaceuticals Private Limited amount to ₹ 0.70 M.

  • When was the last Balance Sheet of Menald Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Menald Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development